The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015
Abstract
PURPOSE Effectively measuring progress in delivering HIV pre-exposure prophylaxis (PrEP) requires subnational estimates of the number of adults with indications for its use that account for differences in HIV infection rates by transmission risk (risk) group and race/ethnicity. METHODS We applied a multiplier method with 2015 Centers for Disease Control and Prevention surveillance data on proportions of HIV diagnoses by race/ethnicity and risk group and population-based estimates of risk group sizes to derive estimated numbers of adults with indications by risk group (men who have sex with men [MSM], heterosexually active adults [HET], and persons who inject drugs [PWID]) by race/ethnicity in each jurisdiction. RESULTS An estimated 1.1 million adults had indications for PrEP use in 2015: 813,970 MSM, 258,080 HET, and 72,510 persons who inject drugs, and 500,340 blacks, 282,260 Latinos, and 303,230 whites. Among HET, 176,670 females and 81,410 males had indications. The proportions of adults with indications in each risk and race/ethnicity group varied by jurisdiction. CONCLUSIONS Blacks comprised the highest number of adults with indications showing that increasing PrEP use in this population must be the highest priority. MSM remain a priority because of the high number with indications. These estimates can be used as denominators to assess PrEP coverage and impact on HIV incidence at subnational levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The RE-AIM framework: a systematic review of use over time
Gaglio, B., Shoup, J. A., & Glasgow, R. E. (2013) · American Journal of Public Health · doi:10.2105/ajph.2013.301299 · Cited by 1,029
HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015
Peters, P. J., Pontones, P., Hoover, K. W., Patel, M. R., Galang, R. R., Shields, J., Blosser, S. J., Spiller, M. W., Combs, B., Switzer, W. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515195 · Cited by 594
Defining the HIV pre-exposure prophylaxis care continuum
Nunn, A. S., Brinkley-Rubinstein, L., Oldenburg, C. E., Mayer, K. H., Mimiaga, M., Patel, R., & Chan, P. A. (2017) · AIDS · doi:10.1097/qad.0000000000001385 · Cited by 362
Lifetime risk of a diagnosis of HIV infection in the United States
Hess, K. L., Hu, X., Lansky, A., Mermin, J., & Hall, H. I. (2017) · Annals of Epidemiology · doi:10.1016/j.annepidem.2017.02.003 · Cited by 356
Purcell, D. W., Johnson, C. H., Lansky, A., Prejean, J., Stein, R., Denning, P., Gau1, Z., Weinstock, H., Su, J., & Crepaz, N. (2012) · The Open AIDS Journal · doi:10.2174/1874613601206010098 · Cited by 356
Smith, D. K., Van Handel, M., Wolitski, R. J., Stryker, J. E., Hall, H. I., Prejean, J., Koenig, L. J., & Valleroy, L. A. (2015) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6446a4 · Cited by 352
Self-citationApplying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, Georgia
Kelley, C. F., Kahle, E., Siegler, A., Sanchez, T., del Rio, C., Sullivan, P. S., & Rosenberg, E. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ664 · Cited by 298
Grey, J. A., Bernstein, K. T., Sullivan, P. S., Purcell, D. W., Chesson, H. W., Gift, T. L., & Rosenberg, E. S. (2016) · JMIR Public Health and Surveillance · doi:10.2196/publichealth.5365 · Cited by 210
Self-citationUptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons—United States, 2010–2014
Wu, H., Mendoza, M. C. B., Huang, Y.-L. A., Hayes, T., Smith, D. K., & Hoover, K. W. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw701 · Cited by 126
Self-citationCampbell, E. M., Jia, H., Shankar, A., Hanson, D. L., Luo, W., Masciotra, S., Owen, S. M., Oster, A. M., Galang, R. R., Spiller, M. W., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix307 · Cited by 122
Cited by
Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review
Mayer, K. H., Agwu, A., & Malebranche, D. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01295-0 · Cited by 426
HIV Preexposure Prophylaxis, by Race and Ethnicity — United States, 2014–2016
Huang, Y.-L. A., Zhu, W., Smith, D. K., Harris, N., & Hoover, K. W. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6741a3 · Cited by 420
Self-citationHTLV-1 Transmission and HIV Pre-exposure Prophylaxis: A Scoping Review
Bradshaw, D., & Taylor, G. P. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.881547 · Cited by 12
Metadata
- Authors
- Smith, D. K., Van Handel, M., & Grey, J.
- Venue
- Annals of Epidemiology
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 28
- Issue
- 12
- Pages
- 850-857.e9
- ISSN
- 1047-2797 (ISSN-L)
- OpenAlex
- W2803585474
- Cited by
- 273
- References
- 11
- FWCI
- 24.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. https://app.cochat.ai/papers/10.1016/j.annepidem.2018.05.003
- The paper
- Smith, D. K., Van Handel, M., & Grey, J. (2018). Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Annals of Epidemiology. https://doi.org/10.1016/j.annepidem.2018.05.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.